Liposome encapsulated hemoglobin as a resuscitation fluid for hemorrhagic shock

Artificial Organs

Volumn 22, Issue 2, 1998, Pages 116-122

  Usuba, Akira ^a   Osuka, Fumihiko ^a   Kimura, Takashi ^a   Sato, Ryo ^a   Fujita, Yasuki ^a   Yamashita, Michitoshi ^a   Hoshino, Chisho ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Artificial blood; Blood substitute; Hemorrhagic shock; Liposome encapsulated hemoglobin; Oxygen carrier; Resuscitation fluid

Indexed keywords

BLOOD; HEMOGLOBIN; OXYGEN SUPPLY;

CARDIAC INDEXES; CELL-BE; CELL/B.E; CELL/BE; HEMORRHAGIC SHOCK; LIPOSOME ENCAPSULATED HEMOGLOBINS; OXYGEN CARRIER; OXYGEN TRANSPORT; RED CELLS; RESUSCITATION FLUID;

RESUSCITATION;

BLOOD SUBSTITUTE; HEMOGLOBIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SUBSTITUTION; CONTROLLED STUDY; DOG; ENCAPSULATION; ERYTHROCYTE; HEART INDEX; HEMORRHAGIC SHOCK; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; RESUSCITATION; VASCULAR RESISTANCE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031911608     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Burk O, Hearon J, Gasolin L. Reversible complex of cobalt histidine and oxygen gas. J Biol Chem 1946;165:723-4.
2. Clark LC, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen atmospheric pressure. Science 1966;152:1755-6.
3. Yokoyama K, Yamanouchi K, Watanabe M, Matsumoto T, Murashima R, Daimoto T, Hamano T, Okamoto H, Suyama T, Watanabe R, Naito R. Preparation of perfluorodecalin emulsion, an approach to the red cell substitute. Fed Proc 1975;34:1468-77.
4. Honda K, Hoshino S, Shoji M, Usuba A, Motoki R, Tsuboi M, Inoue H, Iwaya F. Clinical use of blood substitute. N Engl J Med 1980;303:391-2.
5. Marwick C. FDA committee questions Fluosol efficacy; US approval not imminent. JAMA 1983;250:2585-6.
6. Mitsuno T, Ohyanagi H, Naito R. Clinical studies of perfluorochemical whole blood substitute (Fluosol-DA). Ann Surg 1982;195:60-9.
7. Snyder SR, Welty EV, Walder RY, Williams LA, Walder TA. HbxL99 alpha: A hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute. Proc Natl Acad Sci USA 1987;84:7280-4.
8. Clerc Y, Dubos M, Bihoreau N, Delamourd L, Brasseur C, Gond B, Goyffon M, Saint-Blancard J. Pyridoxylated polymerized hemoglobin solution processing. Interest of a membrane molecular fractionation step. Appl Biochem Biotechnol 1987;14:241-51.
9. Iwasaki K, Iwashita Y. Preparation and evaluation of hemoglobin polyethylene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid. Artif Organs 1986;10:411-6.
10. Djordjevich L, Miller IF. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol 1980;8:584-92.
11. Farmer MC, Gaber BP. Liposome encapsulated hemoglobin as an artificial oxygen-carrying system. Methods Enzymol 1987;149:184-200.
12. Rudolph AS. Encapsulation of hemoglobin in liposomes. In: Winslow RM, Vandegriff KD. Intaglietta M, eds. Blood substitutes: Physiological basis of efficacy. Boston: Birkhauser, 1995:90-104.
13. Usuba A, Motoki R, Miyauchi Y, Suzuki K, Takahashi A. Effect of neo red cells on the canine hemorrhagic shock model. Int J Artif Organs 1991;14:739-44.
14. Motoki R, Honda K. Hemodynamics in sepsis: Its relationship to pulmonary complication. Tohoku J Exp Med 1977;123: 109-24.
15. Usuba A, Motoki R. Safety and efficacy of encapsulated hemoglobin in hemorrhagic shock. In: Tsuchida ed. Artificial red cells. New York: John Wiley & Sons. 1995:65-92.
16. Usuba A, Endoh Y, Motoki R, Ogata Y, Suzuki K, Kamitani T. Neo red cells in a canine hemorrhagic shock model. In: Shek PN ed. Liposomes in biomedical applications. Amsterdam: Harwood Academic Publishers, 1995:265-81.
17. Winslow RM. Blood substitute oxygen carriers designed for clinical applications. In: Winslow RM, Vandegriff KD, Intaglietta M, eds. Blood substitutes: New challenges. Boston: Birkhauser, 1996:60-72.
18. Usuba A, Motoki R, Ogata Y, Suzuki K, Kamitani T. Effect and safety of liposome-encapsulated hemoglobin neo red cells (NRCs) as a perfusate for total cardiopulmonary bypass. Art Cells Blood Subs and Immob Biotech 1995;23:337-46.
19. Honda K, Usuba A, Miyazawa M, Motoki R, Kanno M, Honda M, Iwaya F, Hoshino S, Yamanouchi K, Yokoyama K, Sakaguchi K, Suzuki K, Kamitani T, Takahashi A. Development of artificial blood; from Fluosol-DA (FDA) to neo red cells (NRC). Biomater Living Syst Interact 1993;1:73-84.
20. Usuba A, Motoki R, Suzuki K, Sakaguchi K, Takahashi A. Study of the effect of the newly developed artificial blood "neo red cells (NRC)" on hemodynamics and blood gas transport in canine hemorrhagic shock. Biomater Art Cells Immob Biotech 1992;20:531-5.
21. Usuba A, Motoki R, Sakaguchi K, Suzuki K, Kamitani T. Effect of neo red cells on the hemodynamics and blood gas transport in canine hemorrhagic shock and its safety for vital organs. Biomater Art Cells Blood Subs and Immob Biotech 1994;22:503-16.
22. Usuba A, Motoki R, Sakaguchi K, Suzuki K, Kamitani T, Takahashi A. Oxygen transport capacity and hemodynamic effect of newly developed artificial blood "neo red cells (NRC)" XXVIII World Congress of the International College of Surgeons Bologna: Monduzzi Editore, 1992:803-6.
23. Usuba A, Miyazawa M, Miura J, Endoh Y, Motoki R, Sakaguchi K, Suzuki K, Takahashi A. Oxygen transport capacity and hemodynamic effects of newly developed artificial blood "neo red cells (NRC)" Artif Organs Today 1993;2:299-308.
24. Usuba A, Miyazawa M, Motoki R, Sakaguchi K, Suzuki K, Kamitani T, Takahashi A. Oxygen transport capacity and hemodynamic effect of newly developed artificial blood "neo red cells (NRC)" Int J Artif Organs 1993;16:551-6.
25. Stephens KE, Ishizaka A, Larrick JW. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis 1988;137:1367-70.
26. Shoemaker WC, Appel PL, Kram HB. Tissue oxygen debt as a determinant of lethal and nonlethal postoperative organ failure. Crit Care Med 1988;16:1117-20.